APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
暂无分享,去创建一个
A. Vincent-Salomon | I. Bièche | V. Bécette | D. Stoppa-Lyonnet | B. Buecher | V. Suybeng | E. Mouret‐Fourme | G. Bataillon | C. Colas | L. Golmard | V. Moncoutier | Mathias Schwartz | J. Le Gall | O. Trabelsi-Grati | Roseline Vibert | C. Dehainault | J. Carrière
[1] C. Parra‐Herran. Endometrioid Tubal Intraepithelial Neoplasia and Bilateral Ovarian Microcystic Stromal Tumors Harboring APC Mutations: Report of a Case. , 2021, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[2] A. Casamassimi,et al. Double mutation of APC and BRCA1 in an Italian family. , 2020, Cancer genetics.
[3] François-Clément Bidard,et al. ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing , 2020, Bioinform..
[4] S. Salvi,et al. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? , 2020, International journal of molecular sciences.
[5] N. Phillips,et al. Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations. , 2019, Archives of pathology & laboratory medicine.
[6] B. Solomon,et al. Germline pathogenic variants identified in women with ovarian tumors. , 2018, Gynecologic oncology.
[7] R. N. Fogace,et al. Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management , 2018, Clinics.
[8] Yuling Fu,et al. Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer , 2016, Journal of Ovarian Research.
[9] W. Hung,et al. APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice , 2016, Oncogene.
[10] D. Venter,et al. Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[11] Li Ding,et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. , 2015, The New England journal of medicine.
[12] H. Cha,et al. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis , 2015, Genes, chromosomes & cancer.
[13] G. Fleuren,et al. Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissue. , 2015, The Journal of molecular diagnostics : JMD.
[14] M. Newton,et al. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms , 2012, Proceedings of the National Academy of Sciences.
[15] A. Knudson,et al. A continuum model for tumour suppression , 2011, Nature.
[16] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[17] M. Witjes,et al. Extra-Intestinal Manifestations of Familial Adenomatous Polyposis , 2008, Annals of Surgical Oncology.
[18] Kathleen R. Cho,et al. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. , 2007, Cancer cell.
[19] J. Nesland,et al. Adenomatous Polyposis Coli (APC) Protein Expression in Primary and Metastatic Serous Ovarian Carcinoma , 2002, International journal of surgical pathology.
[20] Z. Cohen,et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.
[21] W. Foulkes,et al. Ovarian Microcystic Stromal Tumors Are Characterized by Alterations in the Beta-Catenin-APC Pathway and May be an Extracolonic Manifestation of Familial Adenomatous Polyposis. , 2018, The American journal of surgical pathology.
[22] L. Moreira,et al. The Application of Clinical Genetics Dovepress the Genetic Basis of Familial Adenomatous Polyposis and Its Implications for Clinical Practice and Risk Management , 2022 .